Results 1 to 10 of about 232,869 (199)

The microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study [PDF]

, 2013
<p>Introduction: Children presenting for the first time with inflammatory bowel disease (IBD) offer a unique opportunity to study aetiological agents before the confounders of treatment.
AJ Lastovica, Andy R. Barclay, B Hope, BL Williams, C Huttenhower, Charlotte E. Nicholl, CP Tamboli, D Laharie, D Linton, Dagmar Kastner-Cole, Diana M. Flynn, E El-Omar, EI Benchimol, Emad M. El-Omar, Gamal Mahdi, Georgina L. Hold, GL Hold, HM Wexler, I Mukhopadhya, I Mukhopadhya, I Mukhopadhya, Indrani Mukhopadhya, J Qin, J Van Limbergen, JE Lennard-Jones, JG Fox, JI Keenan, JL Benach, JL Round, JM Thomson, John M. Thomson, Jon Bishop, Karin A. Saunders, L Jostins, L Zhang, L Zhang, M Grehan, M Grehan, M Imielinski, M Kverka, MP Kronman, NO Kaakoush, P Henderson, Paraic McGrogan, PB Eckburg, R Hansen, R Hansen, R Hansen, Richard Hansen, Richard K. Russell, S Kugathasan, Sabarinathan Loganathan, SJ Bell, SK Lathrop, SM Collins, SM Man, SM Man, SM Man, Stefan Bereswill, Susan H. Berry, SY Shaw, URM Bohr, V Mahendran, W. Michael Bisset   +63 more
core   +19 more sources

Clinical Predictive Factors of Response to Biologics in IBD [PDF]

Modern Medicine, 2022
Background: Growing insights into complex molecular pathways involved in the pathogenesis of inflammatory bowel diseases (IBD) have led to advent of new treatment options. Currently, there are three classes of biological agents approved for the treatment
Roxana SADAGURSCHI, A. DOBROMIRESCU, Ruxandra BABIUC, Lucian NEGREANU   +3 more
doaj   +1 more source

Bowel Ultrasound in Inflammatory Bowel Disease: How Far in the Grayscale?

Life, 2021
Bowel ultrasound (BUS) is a non-invasive and accurate technique for assessing activity, extension of disease, and complications in inflammatory bowel diseases. The main advantages of BUS are its safety, reproducibility, and low costs.
Federica Furfaro, Arianna Dal Buono, Mariangela Allocca, Ferdinando D'Amico, Alessandra Zilli, Roberto Gabbiadini, Silvio Danese   +6 more
doaj   +1 more source

Impact of Immunotherapies on SARS-CoV-2-Infections and Other Respiratory Tract Infections during the COVID-19 Winter Season in IBD Patients

Canadian Journal of Gastroenterology and Hepatology, 2022
Background. COVID-19 represents one of the most significant medical problems of our time. Aims. This study is focused on the question whether patients with inflammatory bowel disease (IBD) who receive immunotherapies are more vulnerable to respiratory ...
Constanze Heike Waggershauser, Cornelia Tillack-Schreiber, Paul Weyh, Eckard Alt, Thorsten Siegmund, Christine Berchthold-Benchieb, Daniel Szokodi, Fabian Schnitzler, Thomas Ochsenkühn   +8 more
doaj   +1 more source

Monitoring of leucine‐rich alpha‐2‐glycoprotein and assessment by small bowel capsule endoscopy are prognostic for Crohn's disease patients

JGH Open, 2023
Background and Aim Endoscopy is important to determine the effectiveness of treatment for Crohn's disease (CD), but searching the entire small intestine is difficult.
Takahiro Ito, Kazuki Dai, Masashi Horiuchi, Toshiki Horii, Shigeru Furukawa, Atsuo Maemoto   +5 more
doaj   +1 more source

SAPHO Syndrome in Crohn’s Disease Successfully Treated with Ustekinumab: Case Report and Review of the Literature

European Medical Journal Gastroenterology, 2023
The authors report a case of synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome in a patient with Crohn’s disease (CD). SAPHO syndrome is a rare disease characterised by the association, even if not simultaneous, of joint and skin ...
Sara Caporuscio, Daniela Maggi, Annalisa Aratari, Claudio Papi, Stefano Festa   +4 more
doaj   +1 more source

Seroprevalence of ANTI-SARS-CoV-2 antibodies in patients with inflammatory bowel disease

Scientific Reports, 2023
Patients with inflammatory bowel disease (IBD) treated with biologic and/or immunosuppressant drugs are at increased risk for opportunistic infections.
M. D. Martin-Arranz, L. García-Ramírez, M. Hernandez-Perez, D. Montero Vega, E. Martín-Arranz, M. Sánchez-Azofra, J. Poza Cordon, J. L. Rueda Garcia, J. Noci Belda, T. Verges Martínez-Meco, P. Blanco San Miguel, C. Suarez Ferrer   +11 more
doaj   +1 more source

Endoscopic Surveillance in Inflammatory Bowel Diseases: Selecting a Suitable Technology

Frontiers in Medicine, 2022
In the treat-to-target era, endoscopy has become the backbone of the assessment of remission, defined as mucosal healing, in inflammatory bowel disease (IBD) patients.
Arianna Dal Buono, Roberto Gabbiadini, Federica Furfaro, Marjorie Argollo, Thaís Viana Tavares Trigo, Alessandro Repici, Alessandro Repici, Giulia Roda   +7 more
doaj   +1 more source

Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels [PDF]

, 2020
Background Inflammatory bowel disease (IBD), is a debilitating group of chronic diseases including Crohn’s Disease (CD) and ulcerative colitis (UC), which causes inflammation of the gut and affects millions of people worldwide.
Alam, Mohammad T., Amos, Gregory C. A., Arasaradnam, Ramesh P., Murch, Simon, Murphy, Andrew, Wellington, E. M. H.   +5 more
core   +1 more source

Milan Ultrasound Criteria Predict Relapse of Ulcerative Colitis in Remission

Inflammatory Intestinal Diseases, 2023
Introduction: Bowel ultrasound is a noninvasive alternative to endoscopy for assessing the disease activity of ulcerative colitis; however, it is unclear whether bowel ultrasound can predict subsequent relapse from remission.
Masa Maeda, Shintaro Sagami, Moyu Tashima, Yoko Yamana, Ryo Karashima, Yusuke Miyatani, Aya Hojo, Masaru Nakano, Toshifumi Hibi, Taku Kobayashi   +9 more
doaj   +1 more source